Atlas Trials

A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis

Clinical trial NCT00659412 · COMPLETED

Trial details

NCT number
NCT00659412
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriatic Arthritis
Start date
2003-09-01
Primary completion
2005-03-01
Enrollment
185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.